Smart Strategies for Savings Presented at ASHP Meeting Pharmacy Practice News The cost for inpatient rituximab (Rituxan, Genentech) alone decreased from baseline by more than $250,000 in FY10 and by $150,000 in FY11. The driving force behind the savings was shifting the location of the infusion from the inpatient setting to the ... |
